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Many spotlights currently illuminate the challenges associated with medical diagnosis. The 
National Academy of Medicine estimates that all patients will experience 1 serious diagnostic 
error during their lifetime, and diagnostic errors are now the leading cause of medical 
malpractice claims (1, 2). To avoid missing diagnoses, clinicians often order imaging and/or 
laboratory studies and initiate specialist referrals. However, physicians and patients are also 
urged to use fewer tests; nearly every U.S. medical specialty and 20 countries worldwide have 
initiated Choosing Wisely campaigns (3). Evidence increasingly shows that indiscriminate 
diagnostic testing and referrals often fail to provide definitive explanations or improve outcomes 
and at times are more harmful than beneficial. 
 
Balancing underdiagnosis (missing or delaying important diagnoses) and wasteful, harmful 
overdiagnosis (labeling patients with diseases that may never cause suffering or death) is often 
portrayed as the need “to keep the pendulum from swinging too far in either direction” (4). 
Rather than framing the problem as a simple, linear tradeoff, we believe it must be more 
fundamentally conceptualized as 2 sides of the same coin unified by the need for more cautious 
and careful approaches. 
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We assembled a diverse group of clinicians, educators, and health policy and communication 
experts to create recommendations to support improved approaches to clinical care and health 
policy (www.patientsafetyresearch.org/Schiff_Ten_Principles_Conservative_Diagnosis.pdf). 
Building on our previous conservative principles of medication prescribing (5), we developed 10 
overarching principles based on core attributes of care (good communication, trusting 
relationships, and continuity of care) and key patient safety lessons (awareness of pitfalls, safety 
nets to mitigate harm, and a culture that facilitates learning/avoiding blame) that go beyond 
current test-by-test recommendations. 
Promoting Enhanced Caring and Listening 
Patients come to clinicians seeking explanations for their symptoms. Clinicians often rely on 
laboratory and imaging studies and specialist referrals to rule out serious diagnoses and identify 
patients who could benefit from particular treatments. However, this approach rests on the 
questionable assumptions that testing is key to making an accurate diagnosis, an exact diagnosis 
is always available and needed to select therapies, and ordering tests best shows that clinicians 
are taking patients' concerns seriously. 
 
Medicine currently shortchanges the patient history and physical examination, even though 
carefully listening to and observing patients over time often provide more valuable information 
than multiple radiologic or chemical tests. We must stop equating testing with caring and 
thoroughness and instead emphasize respectful listening, examination, follow-up, and 
collaboration with the patient to “coproduce” diagnoses (1, 6). 
Developing a New Science of Uncertainty 
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As precision medicine becomes a major preoccupation, appreciation of the pervasiveness of 
uncertainty in medicine has paradoxically increased (7). We need to develop a new science and 
praxis of diagnostic uncertainty that acknowledges complex biological and social systems and 
serves as a starting point for more modest, reflective, and conservative practice. Doing so 
requires acknowledging widespread uncertainty, better operationalizing follow-up, and 
communicating honestly about uncertainty. 
Rethinking Symptoms 
Up to one half of symptoms defy definitive medical diagnosis. Further, many symptoms are self-
limiting: 75% to 80% of symptoms improve over 4 to 12 weeks, usually regardless of medical 
intervention (8). Some patients meet criteria for depression, anxiety, or somatoform illnesses, yet 
these diagnoses are overlooked in two thirds of patients. Visits for “medically unexplained 
symptoms” currently represent the fastest-growing type of medical encounter. Caring for these 
patients can be frustrating, leading clinicians to be dismissive or stigmatizing. We need to move 
away from exhaustively trying to rule out multiple rare diseases and then labeling patients' 
symptoms as nonorganic, toward more helpful and supportive approaches. 
Maximizing Continuity and Trust 
Continuity is the foundation of judicious clinical practice. Without knowledgeable, trusting 
relationships, clinicians must often resort to defensive, inadequately informed, and costly styles 
of practice. Health systems that maximize relational and informational continuity perform better 
and cost less (9), and patients value having clinicians who know them well. Financial incentives 
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can undermine long-term, trusting relationships. If clinicians are incentivized to withhold tests, 
patients may find trusting “watch-and-wait” recommendations difficult (3). 
Taming and Taking Time 
Time is the currency of clinical care. Although few clinicians would disagree in principle with 
the conservative diagnosis practices that we advocate, many argue that they simply do not have 
time for prolonged discussions about uncertainty, exploration of symptoms in greater detail, or 
comprehensive follow-up. Time is a powerful incubator for diagnosis. Conservative diagnosis 
requires carefully and skillfully weighing information as it evolves. Having adequate time to 
listen, observe, discuss, and reflect is a decisive factor that separates good diagnosis from under- 
and overdiagnosis. Practical strategies include redesigning care to optimize the roles of other 
team members and reengineering electronic health records and follow-up systems to support 
watchful waiting, a fundamental pillar of conservative diagnosis and an antidote to the 
unwatchful neglect that patients fear (10). 
Linking Diagnosis to Treatment 
Diagnosis needs to stand less alone and more arm in arm with treatment. The value of diagnosis 
is greater in conditions with effective, specific, or urgent treatments and more limited if no 
therapy is available, a diagnosis is not needed to select among treatment options, and/or 
treatment can be safely deferred. Diagnosing conditions for which patients have no interest in 
being treated (for example, chemotherapy and surgery) may be unwarranted and disrespectful. 
Ordering and Interpreting Tests More Thoughtfully 
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Conservative diagnosis is not just saying “no” to tests or the patients requesting them. Rather, it 
is about more intelligently selecting, timing, sequencing, interpreting, and weighing the marginal 
benefits of tests. Few appreciate the biases and lack of rigor involved in evaluating new 
diagnostic tests, which are not subject to the same evidence and regulatory standards as 
medications. We also often do not fully consider the potential harms of testing (Table). 
Safety Nets: Incorporating Lessons From Diagnostic Errors 
Recent attention given to diagnostic errors might seem to argue for more aggressive defensive 
medicine to rule out myriad diagnoses lest they be missed and labeled as errors and delays. 
However, additional testing does not necessarily result in answers that patients and clinicians 
seek. Being aware of potential diagnostic errors can help avoid pitfalls and build safety nets and 
systems to protect against known errors. 
Addressing Cancer: Fears and Challenges 
Patients understandably fear missed cases of cancer. Almost any symptom can be due to cancer. 
Clinicians and the media have long promoted early diagnosis, but serious controversies surround 
efforts to screen for and diagnose most types of cancer. These issues are complex. Furthermore, 
data are often inconclusive or conflicting, particularly considering such issues as lead-time bias; 
overdiagnosis of cancer that is incidentally discovered but best left untreated; false-positive and 
false-negative test results; uncertainties about the value of treatment; and questions about the 
marginal benefit of early treatment. We need to help patients understand the toll imposed by 
false-positive results and overdiagnosed cancer to appreciate the need to strike a balance between 
treating the few with harmful cancer and avoiding harm to the many without it. 
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Diagnostic Stewardship: Transforming the Role of Specialists and Emergency Department 
Clinicians 
Implicit in conservative diagnosis is minimizing indiscriminate use of specialty referrals and 
emergency departments. However, both specialists and emergency department clinicians can 
positively contribute by leveraging their knowledge and playing stewardship roles. Specialists 
can provide guidance when testing or referring is not needed and offer safety nets (such as triage 
electronic consultations/second opinions and guidelines) to conservatively assess and reassure 
patients. Emergency department clinicians can work with primary care clinicians to help reduce 
unnecessary emergency department visits while helping to expedite truly urgent evaluations. 
Conclusion 
Achieving more judicious diagnosis mandates policy support to redesign care at both the 
individual patient and system levels. Practical safety nets can protect the safety and quality of 
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Table. Potential Harms from Diagnostic Testing* 
Direct Harm 
Complications from invasive tests 
Unstable patients leaving more protected environments to undergo tests 
Delays in initiation of urgent treatment while waiting for tests and results 
Adverse reactions (e.g., renal toxicity and anaphylaxis) from contrast or other diagnostic agents 
Local complications from phlebotomy and catheter access (e.g., hematoma, contamination, pain from 
multiple venipuncture sticks, and wounds) and loss of future venous access 
Imaging-associated cancer and other harms from radiation 
 
Downstream Harm 
Harm from further work-up and treatment of false-positive test results (especially failure to account 
for the poor predictive value of positive results in the context of low prior probability) 
Harm from treatment caused by overdiagnosis (i.e., diagnosis of conditions that, although correctly 
diagnosed, would never have caused harm or required treatment) 
False reassurance (i.e., complacency or failure to treat as a result of a false-negative result) 
Harm from additional testing, such as cascades after an initial false-positive result or overdiagnosis 
Conveying a message to patients that promotes a culture of indiscriminate testing 
Treatment of asymptomatic risk factors with interventions that cause 
 
Harm Intrinsic to Making a Diagnosis 
Stigmatizing labels that may outweigh any benefits of the diagnosis for a patient 
Anxiety from diagnoses that would not otherwise have been discovered or treated 
Increased burden of illness (e.g., more medication regimens, appointments, and procedures and lost 
work time and greater family burden) 
Distraction of clinicians' and patients' attention from more beneficial diagnostic activities (e.g., 
obtaining a better history and serial examinations) and treatment 
 
* The risk for these adverse effects may be more or less frequent de-pending on the test, patient, or 
context but need to be recognized, weighed, and minimized when ordering and performing diagnostic 
tests. 
